Media hub
-
Research grant to advance ovarian cancer treatment
The Centenary Institute has received vital grant funding from Cancer Australia to lead new research efforts targeting chemotherapy resistance in ovarian cancer patients.News Type: Media releaseDate -
Grant to boost research into age-related blood vessel health
The Centenary Institute’s Professor Jennifer Gamble has been awarded a Senior Researcher Grant under the NSW Cardiovascular Research Capacity Program receiving a total of $750,000 over three years. The grant will fund Professor Gamble’s research into vascular (blood vessel) health to aid healthy ageing and to help prevent disease.News Type: Media releaseDate -
Research reveals gut’s crucial role in lung disease
Research led by the Centenary Institute, the University of Technology Sydney and the Hunter Medical Research Institute suggests that the gut microbiome plays a pivotal role in the development of chronic obstructive pulmonary disease (COPD), paving the way for new therapeutic treatments.News Type: Media releaseDate -
T cells team-up to protect the liver from infection
Researchers at the Centenary Institute have made an important breakthrough in understanding how the immune system fights off infections in the liver – paving the way for more specific and effective therapies to treat and prevent liver diseases such as viral hepatitis and fatty liver disease, and decrease the risk of liver transplant rejection.News Type: Media releaseDate -
Research aims to transform haemophilia treatment
Professor Philip Hogg, researcher in the Centenary Institute's Centre for Cancer Innovations, has received a National Health and Medical Research Council (NHMRC) Investigator Grant to undertake research aimed at revolutionising the treatment of haemophilia A.News Type: Media releaseDate -
Centenary researchers awarded more than $2m in Ideas Grants
Centenary Institute researchers have successfully secured over $2 million in combined funding from the Federal Government in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants.News Type: Media releaseDate -
New technology, ‘Invasion-Block’, targets melanoma spread
Research conducted at the Centenary Institute has given rise to a ground-breaking tool called 'Invasion-Block' that can identify drugs capable of halting the spread of cancer cells. The pioneering development could lead to better treatments for melanoma, the most dangerous form of skin cancer.News Type: Media releaseDate -
Pivotal role of TLR7 protein revealed in lung disease
The discovery, led by the Centenary Institute and the University of Technology Sydney, could advance treatments for COPD, a lung condition that makes it difficult to breathe due to narrowed airways and damaged lung tissue. COPD is often caused by smoking or exposure to irritants. Lead study researcher, Dr Gang Liu at the Centenary UTS ...News Type: Media releaseDate -
ARC grant to fuel research into cellular ageing
Centenary Institute researchers have been awarded an Australian Research Council (ARC) Discovery Project grant worth $709,714 to advance understanding of the intricate mechanisms underlying cellular ageing.News Type: Media releaseDate -
Blood vessel breakdown linked with Alzheimer’s disease
Researchers at the Centenary Institute have discovered a connection between the health of blood vessels and the development of Alzheimer’s disease. The findings suggest that early interventions aimed at improving blood vessel health offer an avenue for the advancement of new treatments for Alzheimer’s. A progressive brain disorder, Alzheimer’s disease causes memory loss, cognitive decline ...News Type: Media releaseDate -
Research to unlock the secrets of muscle loss in ageing
The Centenary Institute and the University of Technology Sydney will lead pioneering research into age-related muscle loss, called sarcopenia, with a Dynamic Resilience Program contract from Wellcome Leap.News Type: Media releaseDate -
New treatment offers hope for advanced liver cancer
Researchers have discovered a new way to treat hepatocellular carcinoma (HCC), the most common type of liver cancer and the third leading cause of cancer death worldwide.News Type: Media releaseDate